Elamex Sa De Stock Short Ratio
Fundamental analysis of Elamex SA allows traders to better anticipate movements in Elamex SA's stock price by examining its financial health and performance throughout various phases of its business cycle.
Elamex |
Elamex SA de Company Short Ratio Analysis
Elamex SA's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Elamex SA de has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Food Products sector and 100.0% lower than that of the Consumer Staples industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Elamex Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elamex SA's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Elamex SA could also be used in its relative valuation, which is a method of valuing Elamex SA by comparing valuation metrics of similar companies.Elamex SA is currently under evaluation in short ratio category among its peers.
Elamex Fundamentals
| Return On Equity | -0.0173 | |||
| Return On Asset | 0.0139 | |||
| Profit Margin | (0) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 9.38 M | |||
| Price To Earning | 0.21 X | |||
| Price To Book | 0.55 X | |||
| Price To Sales | 0.13 X | |||
| Revenue | 105 M | |||
| Gross Profit | 21.7 M | |||
| EBITDA | 4.04 M | |||
| Net Income | (2.3 M) | |||
| Cash And Equivalents | 598 K | |||
| Cash Per Share | 0.08 X | |||
| Debt To Equity | 0.45 % | |||
| Current Ratio | 1.13 X | |||
| Book Value Per Share | 3.36 X | |||
| Cash Flow From Operations | 1.5 M | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 11 | |||
| Beta | 1.29 | |||
| Market Capitalization | 13.88 M | |||
| Total Asset | 52.18 M | |||
| Retained Earnings | (8.54 M) | |||
| Working Capital | (1.84 M) | |||
| Current Asset | 22.32 M | |||
| Current Liabilities | 24.17 M | |||
| Z Score | 2.0 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 52.18 M |
About Elamex SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elamex SA de's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elamex SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elamex SA de based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Elamex Pink Sheet
Elamex SA financial ratios help investors to determine whether Elamex Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elamex with respect to the benefits of owning Elamex SA security.